Precursor form of brain‐derived neurotrophic factor and mature brain‐derived neurotrophic factor are decreased in the pre‐clinical stages of Alzheimer's disease

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Neurochemistry

• Publication date

  2005-06-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1111/j.1471-4159.2005.03135.xPMID 15935057
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role of brain-derived neurotrophic factor and NF-κB in neuronal plasticity and survival: From genes to phenotype

  2004cited by this paper
• Cleavage of proBDNF by tPA/Plasmin Is Essential for Long-Term Hippocampal Plasticity

  2004cited by this paper
• Local Effects of BDNF on Dendritic Growth

  2004cited by this paper
• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• Increased proNGF Levels in Subjects with Mild Cognitive Impairment and Mild Alzheimer Disease

  2004influential reference
• Parietal cortex and attention.

  2004cited by this paper
• Insights into the ageing mind: a view from cognitive neuroscience

  2004cited by this paper
• Variant Brain-Derived Neurotrophic Factor (BDNF) (Met66) Alters the Intracellular Trafficking and Activity-Dependent Secretion of Wild-Type BDNF in Neurosecretory Cells and Cortical Neurons

  2004cited by this paper
• Isolated Executive Impairment and Associated Frontal Neuropathology

  2004cited by this paper
• Cholinergic nucleus basalis tauopathy emerges early in the aging‐MCI‐AD continuum

  2004cited by this paper
• Brain-Derived Neurotrophic Factor val66met Polymorphism Affects Human Memory-Related Hippocampal Activity and Predicts Memory Performance

  2003cited by this paper
• Preservation of brain nerve growth factor in mild cognitive impairment and Alzheimer disease.

  2003cited by this paper
• Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer's disease.

  2003influential reference
• Cholinergic plasticity in hippocampus of individuals with mild cognitive impairment: Correlation with Alzheimer's neuropathology

  2003cited by this paper
• BDNF mRNA expression during postnatal development, maturation and aging of the human prefrontal cortex.

  2002cited by this paper
• A new brain‐derived neurotrophic factor transcript and decrease inbrain‐derived neurotrophic factor transcripts 1, 2 and 3 in Alzheimer's disease parietal cortex

  2002influential reference
• Animal model of dementia induced by entorhinal synaptic damage and partial restoration of cognitive deficits by BDNF and carnitine

  2002cited by this paper
• Natural history of mild cognitive impairment in older persons

  2002cited by this paper
• Heterozygous Knock-Out Mice for Brain-Derived Neurotrophic Factor Show a Pathway-Specific Impairment of Long-Term Potentiation But Normal Critical Period for Monocular Deprivation

  2002cited by this paper
• Screening for mild cognitive impairment (MCI) utilizing combined mini‐mental‐cognitive capacity examinations for identifying dementia prodromes

  2002cited by this paper
• Increased BDNF and trk‐B mRNA expression in cortical and limbic regions following formation of a social recognition memory

  2002cited by this paper
• Loss of basal forebrain P75NTR immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease

  2002cited by this paper
• Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment

  2002cited by this paper
• Neurotrophic factors and Alzheimer's disease: are we focusing on the wrong molecule?

  2002influential reference
• Challenging assumptions about Alzheimer's disease: Mild cognitive impairment and the cholinergic hypothesis

  2002cited by this paper
• Down‐regulation of trkA mRNA within nucleus basalis neurons in individuals with mild cognitive impairment and Alzheimer's disease

  2001cited by this paper
• Regulation of Cell Survival by Secreted Proneurotrophins

  2001influential reference
• The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease.

  2001cited by this paper
• Diagnosis of Preclinical Alzheimer's Disease in a Clinical Setting

  2001cited by this paper
• Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas.

  2000influential reference
• Efficacy and Safety of OK-432 Sclerotherapy for Giant Cystic Hygroma in a Newborn

  2000cited by this paper
• Aging, mild cognitive impairment, and Alzheimer's disease.

  2000cited by this paper
• Mild cognitive impairment: transition between aging and Alzheimer's disease.

  2000cited by this paper
• Epilogue: Toward a Comprehensive Theory of Alzheimer's Disease‐Challenges, Caveats, and Parameters

  2000cited by this paper
• Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease

  2000cited by this paper
• Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease.

  2000cited by this paper
• Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease

  1999cited by this paper
• Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment.

  1999cited by this paper
• BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies.

  1999influential reference
• Challenging the cholinergic hypothesis in Alzheimer disease.

  1999cited by this paper
• Entorhinal Cortex β-Amyloid Load in Individuals with Mild Cognitive Impairment

  1999cited by this paper
• Cellular vulnerability in brain aging and Alzheimer's disease. Clinical correlates and molecular background.

  1998cited by this paper
• Molecular pathogenesis of sporadic and familial forms of Alzheimer's disease.

  1998cited by this paper
• A role for BDNF in the late-phase of hippocampal long-term potentiation.

  1998cited by this paper
• Neurofibrillary pathology of Alzheimer's disease and other tauopathies.

  1998cited by this paper
• Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease.

  1997cited by this paper
• Brain-derived neurotrophic factor is reduced in Alzheimer's disease.

  1997influential reference
• Life and death of neurons in the aging brain.

  1997cited by this paper
• Somatostatin and brain-derived neurotrophic factor mRNA expression in the primate brain: decreased levels of mRNAs during aging.

  1997cited by this paper
• Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease

  1996influential reference
• Regional specificity of alterations in NGF, BDNF and NT‐3 levels in Alzheimer's disease

  1996influential reference
• The effects of growth factors on the survival and differentiation of cultured dentate gyrus neurons

  1996cited by this paper
• Autocrine—paracrine Regulation of Hippocampal Neuron Survival by IGF‐1 and the Neurotrophins BDNF, NT‐3 and NT‐4

  1996cited by this paper
• Neurotrophic Factors and Their Receptors

  1995cited by this paper
• Neurotrophic factors and their receptors

  1994cited by this paper
• Hippocampal connectivity and Alzheimer's dementia

  1994influential reference
• Synapse alterations in the hippocampal-entorhinal formation in Alzheimer's disease with and without Lewy body disease.

  1994cited by this paper
• Aging-Associated Cognitive Decline

  1994cited by this paper
• Requirement for BDNF in activity-dependent survival of cortical neurons.

  1994influential reference
• Neurotrophic factors: from molecule to man.

  1994cited by this paper
• Aging-associated cognitive decline. Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization.

  1994cited by this paper
• Three-Dimensional Analysis of the Relationship Between Synaptic Pathology and Neuropil Threads in Alzheimer Disease

  1992cited by this paper
• Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain

  1992cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1991cited by this paper
• BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra

  1991cited by this paper
• Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

  1991cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  1991cited by this paper
• BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease.

  1991cited by this paper
• Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture.

  1990cited by this paper
• Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.

  1984cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• The cholinergic hypothesis of geriatric memory dysfunction.

  1982cited by this paper
• Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain.

  1982cited by this paper
• Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

  1978cited by this paper
• INTERNATIONAL SOCIETY FOR NEUROCHEMISTRY

  1976cited by this paper
• Alzheimer ' s Disease : Cell-Specific Pathology Isolates the Hippocampal Formation

  year unknowncited by this paper

• From wild plant to functional ingredient: phytochemical insights and neuroprotective activity of Melissa officinalis subsp. altissima.

  2026cites this paper
• Trazodone modulates behavioral alterations in scopolamine-induced cognitive deficit by targeting brain-derived neurotropic factor and cAMP response element-binding protein signaling

  2026cites this paper
• Amyloid β Instigates Cardiac Neurotrophic Signaling Impairment, Driving Alzheimer's Associated Heart Disease.

  2026cites this paper
• An exploratory study of behavioral, cognitive, physiological, and microbiota profiles in senior dogs

  2026cites this paper
• Ultrasound-mediated blood-brain barrier opening for targeted neurological drug delivery.

  2026cites this paper
• Unlocking Alzheimer’s Disease: The Role of BDNF Signaling in Neuropathology and Treatment

  2025cites this paper
• BDNF Val66Met Genotype, DNA Methylation, mRNA, and Protein Levels as Potential Blood-Based Biomarkers for Dementia and Cognitive Decline

  2025cites this paper
• Microecologics and Exercise: Targeting the Microbiota–Gut–Brain Axis for Central Nervous System Disease Intervention

  2025cites this paper
• Neurotrophins as Potential Biomarkers for Active Disease and Poor Outcome in Pediatric Acute Lymphoblastic Leukemia

  2025cites this paper
• Cognitive Development and Grey Matter Enhancement via Auto-Generated Neural Impulse Modulation: A Speculative Framework for Alzheimer’s Risk Reduction

  2025cites this paper
• Association Between Irisin Level and Cognitive Function: A Systematic Review and Meta‐Analysis

  2025cites this paper
• Antioxidant, Anti-Inflammatory, and Antiapoptotic Effects of Euterpe oleracea Mart. (Açaí) in Improving Cognition Deficits: Potential Therapeutic Implications for Alzheimer’s Disease

  2025cites this paper
• Intracerebellar upregulation of Rheb(S16H) ameliorates motor dysfunction in mice with SCA2

  2025cites this paper
• Neuronal HDAC9: A key regulator of cognitive and synaptic aging, rescuing Alzheimer’s disease-related phenotypes

  2025cites this paper
• A Novel Brain Penetrable Nanocarrier Delivers Brain‐Derived Neurotrophic Factor to Treat Alzheimer's Disease

  2025cites this paper
• Loss of the APP regulator RHBDL4 preserves memory in an Alzheimer’s disease mouse model

  2025cites this paper
• The Role of Intermittent Fasting and Calorie Restriction in Preventing Neurodegenerative Diseases within the Context of Adult Neurogenesis

  2025cites this paper
• Chronic stress leads to earlier cognitive decline in an Alzheimer's mouse model: The role of neuroinflammation and TrkB.

  2025cites this paper
• Decrypting the Possible Mechanistic Role of Fenofibrate in Alzheimer's Disease and Type 2 Diabetes: The Truth and Mystery

  2025cites this paper
• COMT Genetic Variants and BDNF Level Associations with Cannabinoid Plasma Exposure: A Preliminary Study

  2025cites this paper
• Targeted BDNF upregulation via upstream open reading frame disruption

  2025cites this paper
• The Biological Intersection Between Chemotherapy-Related Cognitive Impairment and Alzheimer Disease

  2025cites this paper
• Impaired BDNF-TrkB trafficking and signalling in Down syndrome basal forebrain neurons

  2025cites this paper
• High intensity interval training and its impact on brain-derived neurotrophic factor: a potential mechanism to reduce early onset dementia

  2025cites this paper
• Psychedelics meet human brain organoids: insights into proteomics and potential for Alzheimer’s disease treatment

  2025cites this paper
• Adipose chemokine ligand CX3CL1 contributes to maintaining the hippocampal BDNF level, and the effect is attenuated in advanced age

  2025cites this paper
• Dual Trajectories of Serum Brain-Derived Neurotrophic Factor and Cognitive Function in People Living with HIV

  2025influential citation
• Deciphering genetic causality between plasma BDNF and 91 circulating inflammatory proteins through bidirectional mendelian randomization

  2025cites this paper
• Modulation of BDNF/TrkB Signalling Pathway in Alzheimer’s Disease: Mechanistic Insights and the Role of Stem Cell Therapy

  2025cites this paper
• Cystathionine γ-lyase is a major regulator of cognitive function through neurotrophin signaling and neurogenesis

  2025cites this paper
• Exploring the role of Transcranial magnetic stimulation in cognitive impairment and sarcopenia: a narrative review

  2025cites this paper
• Neuroprotective and Nootropic Effects of a Standardised Siddha Polyherbal Formulation, Bhiramiyadhi Bhavanai Choornam, Against β-Amyloid-Induced Neurodegeneration.

  2025cites this paper
• Inflammatory and Neurotrophic Factors and Their Connection to Quality of Life in Progressive Supranuclear Palsy—Single-Center Study

  2025cites this paper
• Brain derived neurotrophic factor and secreted amyloid precursor protein‐α response to moderate and high intensity exercise

  2025cites this paper
• From Amyloid to Synaptic Dysfunction: Biomarker-Driven Insights into Alzheimer’s Disease

  2025cites this paper
• Acute effects of high-intensity interval exercise plus whole-body vibration on bone turnover markers, BDNF, irisin, and neurocognitive performance in postmenopausal women.

  2025cites this paper
• Exploring the impact of computer game playing on cognitive function, Alzheimer's disease risk, and brain-derived neurotrophic factor levels: Basic evidence from Mendelian randomization

  2024cites this paper
• New insight of exercise on dementia; combinatory effects of physical and cognitive exercise

  2024cites this paper
• Connecting the Emotional-Cognitive Puzzle: The Role of Tyrosine Kinase (TrkB) Receptor Isoform Imbalance in Age-Related Emotional and Cognitive impairments.

  2024cites this paper
• BDNF Signaling in Vascular Dementia and Its Effects on Cerebrovascular Dysfunction, Synaptic Plasticity, and Cholinergic System Abnormality

  2024cites this paper
• The Association Between Serum Mature and Precursor Brain-Derived Neurotrophic Factor and Neurocognitive Function in People With Human Immunodeficiency Virus: A Longitudinal Study

  2024cites this paper
• Unraveling the therapeutic efficacy of resveratrol in Alzheimer’s disease: an umbrella review of systematic evidence

  2024cites this paper
• Aniracetam: An Evidence-Based Model for Preventing the Accumulation of Amyloid-β Plaques in Alzheimer’s Disease

  2024cites this paper
• Loss of the APP regulator RHBDL4 preserves memory in an Alzheimer’s disease mouse model

  2024cites this paper
• ACD856, a novel positive allosteric modulator of Trk receptors, single ascending doses in healthy subjects: Safety and pharmacokinetics

  2024cites this paper
• Influence of rehabilitation with the use of sulphide and hydrogen sulphide baths on the concentration of the brain-derived neurotrophic factor (BDNF) and selected parameters of cognitive, executive and affect functions in multiple sclerosis patients

  2024cites this paper
• Alzheimer's therapeutic development: shifting neurodegeneration to neuroregeneration.

  2024cites this paper
• Exploring the association of physical activity on cognitive function in older adults from observational and genetic insights: a combined NHANES and Mendelian randomization study

  2024cites this paper
• Neurotrophin growth factors and their receptors as promising blood biomarkers for Alzheimer’s Disease: a gene expression analysis study

  2024cites this paper
• Aging-Related Protein Alterations in the Brain

  2024cites this paper
• Neural reshaping: the plasticity of human brain and artificial intelligence in the learning process.

  2024cites this paper
• Digging into the intrinsic capacity concept: can it be applied to Alzheimer's disease?

  2024cites this paper
• Cell-Penetrating Peptides: Promising Therapeutics and Drug-Delivery Systems for Neurodegenerative Diseases.

  2024cites this paper
• An in vitro analysis of an innovative standardized phospholipid carrier-based Melissa officinalis L. extract as a potential neuromodulator for emotional distress and related conditions

  2024cites this paper
• Penetratin and Mannose-Functionalized Cannabidiol Lipid Nanoparticles Encapsulating the BDNF Gene Reduce Amyloid-Induced Inflammation.

  2024cites this paper
• New BDNF and NT-3 Cyclic Mimetics Concur with Copper to Activate Trophic Signaling Pathways as Potential Molecular Entities to Protect Old Brains from Neurodegeneration

  2024cites this paper
• Hypoxia Pathways in Parkinson’s Disease: From Pathogenesis to Therapeutic Targets

  2024cites this paper
• Flibanserin conquers murine depressive pseudodementia by amending HPA axis, maladaptive inflammation and AKT/GSK/STAT/BDNF trajectory: center-staging of the serotonergic/adrenergic circuitry.

  2024cites this paper
• Effect of bioactive extracts from Eucalyptus globulus leaves in experimental models of Alzheimer's disease.

  2024cites this paper
• Improvement of spatial learning and memory deficits by intranasal administration of human olfactory ecto-mesenchymal stem cells in an Alzheimer's disease rat model.

  2024cites this paper
• Behavioral and Biochemical Effects of an Arylhydrazone Derivative of 5-Methoxyindole-2-Carboxylic Acid in a Scopolamine-Induced Model of Alzheimer’s Type Dementia in Rats

  2024cites this paper
• Understanding the mechanisms of disease modifying effects of aerobic exercise in people with Alzheimer's disease.

  2024cites this paper
• Spotlight on Coenzyme Q10 in scopolamine-induced Alzheimer's disease: oxidative stress/PI3K/AKT/GSK 3ß/CREB/BDNF/TrKB.

  2023cites this paper
• Exercise training and BDNF injections alter APP processing enzymes and improve cognition.

  2023cites this paper
• Under the umbrella of depression and Alzheimer's disease physiopathology: can cannabinoids be a dual-pleiotropic therapy?

  2023cites this paper
• LPS priming before plaque deposition impedes microglial activation and restrains Aβ pathology in the 5xFAD mouse model of Alzheimer's disease.

  2023cites this paper
• Investıgatıon of the protectıve effect of long-term exercıse on molecular pathways and behavıours ın scopolamıne ınduced alzheımer's dısease-lıke condıtıon.

  2023cites this paper
• Safety, Tolerability, Pharmacokinetics and Quantitative Electroencephalography Assessment of ACD856, a Novel Positive Allosteric Modulator of Trk-Receptors Following Multiple Doses in Healthy Subjects

  2023cites this paper
• Zinc and Central Nervous System Disorders

  2023cites this paper
• Comprehensive characterization of the neurogenic and neuroprotective action of a novel TrkB agonist using mouse and human stem cell models of Alzheimer’s disease

  2023cites this paper
• Insomnia Impairs Both the Pro-BDNF and the BDNF Levels Similarly to Older Adults with Cognitive Decline: An Exploratory Study

  2023cites this paper
• Changes in Loneliness, BDNF, and Biological Aging Predict Trajectories in a Blood-Based Epigenetic Measure of Cortical Aging: A Study of Older Black Americans

  2023cites this paper
• Effect of BRD4 Inhibitor on Cognitive Deficit and c-Fos /BDNF level in rats with Alzheimer's disease

  2023cites this paper
• Boldine modulates glial transcription and functional recovery in a murine model of contusion spinal cord injury

  2023cites this paper
• The Role of BDNF as a Biomarker in Cognitive and Sensory Neurodegeneration

  2023cites this paper
• Molecular Aspects of a Diet as a New Pathway in the Prevention and Treatment of Alzheimer’s Disease

  2023cites this paper
• Serum brain-derived neurotrophic factor as diagnosis clue for Alzheimer's disease: A cross-sectional observational study in the elderly

  2023cites this paper
• Role of primary aging hallmarks in Alzheimer´s disease

  2023cites this paper
• Increase in Effect of Citrus natsudaidai on Brain-Derived Neurotrophic Factor.

  2023cites this paper
• Characterization and Exploration of the Neuroprotective Potential of Oat-Protein-Derived Peptides in PC12 Cells and Scopolamine-Treated Zebrafish

  2023cites this paper
• Difference in Methylation and Expression of Brain-Derived Neurotrophic Factor in Alzheimer’s Disease and Mild Cognitive Impairment

  2023cites this paper
• How does apolipoprotein E genotype influence the relationship between physical activity and Alzheimer’s disease risk? A novel integrative model

  2023cites this paper
• Intranasal insulin intake and exercise improve memory function in amyloid-β induced Alzheimer's-like disease in rats: Involvement of hippocampal BDNF-TrkB receptor.

  2023cites this paper
• Baseline serum brain-derived neurotrophic factor association with future cognition in community-dwelling older adults undergoing annual memory screening

  2023cites this paper
• Role of nerve growth factor on cognitive impairment in patients with Alzheimer's disease carrying apolipoprotein E ε4

  2023cites this paper
• TrkB/BDNF signaling pathway and its small molecular agonists in CNS injury.

  2023cites this paper
• Neuroprotective effect of isovaleraldehyde accompanied with upregulation of BDNF and CREB phosphorylation via the PKA pathway

  2023cites this paper
• Successful Management of Ibrutinib-Induced Thrombocytopenia in a Patient with Chronic Lymphocytic Leukemia: No Interruption, Only Reduction

  2023cites this paper
• Bridging Neurotrophic Factors and Bioactive Peptides to Alzheimer's Disease.

  2023cites this paper
• Comparative assessment of Alzheimer’s disease-related biomarkers in plasma and neuron-derived extracellular vesicles: a nested case-control study

  2023cites this paper
• Early treatment with an M1 and sigma-1 receptor agonist prevents cognitive decline in a transgenic rat model displaying Alzheimer-like amyloid pathology.

  2023cites this paper
• Boldine modulates glial transcription and functional recovery in a murine model of contusion spinal cord injury

  2023cites this paper
• Neuron-derived extracellular vesicles in blood reveal effects of exercise in Alzheimer’s disease

  2023cites this paper
• Adipocyte-Derived Small Extracellular Vesicles from Patients with Alzheimer Disease Carry miRNAs Predicted to Target the CREB Signaling Pathway in Neurons

  2023cites this paper
• Serum levels of brain‐derived neurotrophic factor in remission, but not the acute phase, may predict the development from depression to dementia

  2023cites this paper
• Mechanisms of the Beneficial Effects of Exercise on Brain-Derived Neurotrophic Factor Expression in Alzheimer’s Disease

  2023cites this paper
• Zein-Based Nanoparticles Improve the Therapeutic Efficacy of a TrkB Agonist toward Alzheimer's Disease.

  2023cites this paper
• The Role of Astrocytes and Blood–Brain Barrier Disruption in Alzheimer’s Disease

  2023cites this paper
• Iron overload suppresses hippocampal neurogenesis in adult mice: Implication for iron dysregulation‐linked neurological diseases

  2023cites this paper
• Alterations of Plasmatic Biomarkers of Neurodegeneration in Mucopolysaccharidosis Type II Patients Under Enzyme Replacement Therapy

  2023cites this paper